NEW YORK, March 20, 2023 /PRNewswire/ --
WHY: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) resulting from allegations that Sarepta may have issued materially misleading business information to the investing public.
Read more at prnewswire.com